The FDA Suppressed Its Own Research Showing Covid and Shingles Vaccines Are Safe

FDA scientists conducted a large-scale study using Medicare data and found no alarming safety signals for Covid-19 and shingles vaccines. Instead of publishing the findings, FDA leadership—under the current administration—blocked the research from going public. The suppression of pro-safety data is a significant and unusual move that has alarmed public health researchers and medical professionals.

What the Research Found

The study, which analyzed data from millions of Medicare beneficiaries, examined whether Covid-19 vaccines and the Shingrix shingles vaccine were associated with serious adverse events. The conclusion was reassuring:

• No new safety concerns were identified for the Covid-19 vaccines studied
• Shingrix, already considered highly effective and well-tolerated, was similarly cleared
• The methodology used—large-scale claims data analysis—is considered a gold standard for post-market vaccine surveillance

This is exactly the kind of independent, government-run safety monitoring the public is supposed to be able to trust.

Why the FDA Blocked It

Sources familiar with the situation told The New York Times that FDA Commissioner Robert Califf's successor appointees under the current administration intervened to prevent publication. The rationale offered internally was vague, with no scientific objection raised against the study's methods or conclusions.

Critics point to a broader pattern:

• Robert F. Kennedy Jr., now heading the Department of Health and Human Services, has long promoted vaccine skepticism
• Several senior FDA and CDC officials with strong pro-vaccine records have departed or been pushed out in recent months
• The suppression fits a pattern of sidelining scientific outputs that contradict a politically preferred narrative around vaccines

Notably, this isn't a case of burying dangerous findings—it's the opposite. The findings were favorable to vaccine safety, making the suppression harder to justify on any scientific or public-health grounds.

Why This Matters Beyond the Vaccine Debate

The FDA's credibility rests on its reputation as an independent, science-driven agency. When internal research that confirms safety is blocked from publication, it creates a vacuum that misinformation fills.

The downstream effects are real:

• Physicians lose access to updated, government-generated safety data when making recommendations
• Vaccine-hesitant patients have one less piece of credible evidence available to them
• It sets a precedent that politically inconvenient science can be quietly shelved
• It undermines international trust in U.S. regulatory agencies, which other countries often reference

Public health experts note that transparency—even when findings are mundane or confirmatory—is essential to maintaining institutional trust. A finding that says "this vaccine is safe" is not newsworthy in a vacuum, but the act of hiding it is.

The Bigger Picture

This episode is part of a wider restructuring of federal health agencies under the current administration, with vaccine policy becoming an increasingly politicized battleground. Scientists at the FDA, CDC, and NIH have described a chilling effect on their work, with several noting reluctance to complete or submit studies they fear may be suppressed or used selectively.

The irony is pointed: a government that has questioned vaccine safety data now holds back data that would support vaccine safety. Whatever the political motivation, the result is the same—less information for the public, and less trust in the institutions meant to protect them.